Sharp Therapeutics Corp (TSXV:SHRX)
C$ 0.91 (0%) Market Cap: 27.37 Mil Enterprise Value: 27.83 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 15/100

Sharp Therapeutics Corp Annual Shareholders Meeting Transcript

Jul 21, 2026 / 02:00PM GMT
Release Date Price: C$0.91
Scott Sneddon
Sharp Therapeutics Corp - Chief Executive Officer, Chief Scientific Officer, Director

(audio in progress) Officer of Sharp Therapeutics Corp. I've been designated by William R. Newlin, the Chair of the Board of Directors of the Corporation, to exercise the functions of Chair of the meeting in his absence. To facilitate the meeting, the Corporation has requested that I, a shareholder of the Corporation, make formal motions at the appropriate time.

I would ask that general questions and comments on the current activities of the corporation and other discussions related to specific matters to be voted on at the meeting be reserved until the formal business portion of the meeting is concluded.

With the consent of the meeting, Jason Baibokas will act as Secretary of the Meeting and Dora Wang of Endeavor Trust Corporation, the corporation's registrar and transfer agent, will act as scrutineer of the meeting.

I propose to deal with the formal business of the meeting as set out in the amended and restated Management Information Circular dated June 17, 2026, that was

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot